Sort
40,608 grants matching “prostate cancer”
Precision Antibody Imaging & Radiotherapy of Solid Tumors
$716,609Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · P01 · FY2019 · CA
MR GUIDED PROSTATE CANCER DIAGNOSIS AND BRACHYTHERAPY
$716,581Brigham And Women'S Hospital · R01 · FY2001 · AG
DLL3-targeted IL18-secreting CAR T cells in Small Cell Lung Cancer
$716,521Adam J Schoenfeld · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Identifying Ovarian Cancer Susceptibility Alleles using Genome-Wide Scan Data
$716,356Celeste Leigh Pearce · University Of Southern California · R01 · FY2010 · CA
Transgenic Models for Breast Cancer
$716,309Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Phase II Clinical Trial of Polyphenon E in Prostate Cancer
$715,845Nagi B Kumar · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · CA
Developing the Dietary Inflammatory Index for Clinical Application
$715,682Nitin Shivappa · Connecting Health Innovations, Llc · R44 · FY2015 · DK
Clinical trials employing cancer vaccine combination therapies
$715,531James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
HYPERPOLARIZED 15N MAGNETIC RESONANCE IMAGING OF TUMOR HYPOXIA IN PROSTATE CANCER
$715,500The University Of Texas Southwestern Medical Center · · FY2012 · Department of Defense
Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer:
$715,452Lee W Jones · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
PSMA-Dye Surgical Margin Imaging During Prostatectomy
$715,221Spectros Corporation · R44 · FY2005 · CA
Characterizing the theranostic potential of DLL3-targeting agents in high-grade neuroendocrine carcinomas of the lung and prostate
$715,058Lisa Bodei · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer
$714,893Anna M Wu · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Tissue Array Research Program
$714,730Stephen Hewitt · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
ENHANCEMENT OF RADIATION THERAPY IN PROSTATE CANCER BY DNA-PKCS INHIBITOR
$714,591The University Of Texas Southwestern Medical Center · · FY2011 · Department of Defense
Molecular Mechanisms of Growth Factor Modulated Proliferation
$714,590William Farrar · Basic Sciences · Z01 · FY2007 · CA
Nutritional and Biochemical/Genetic Markers of Cancer
$714,410Jing Ma · Brigham And Women'S Hospital · R01 · FY2007 · CA
Molecular Profiling of the Tumor Microenvironment in Prostate Cancer Progression
$714,317Natasha Kyprianou · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Western New York Cancer Coalition (WNYC2) Center to Reduce Disparities
$714,278Willie Underwood · Roswell Park Cancer Institute Corp · U54 · FY2013 · CA
Novel Targets for Vaccine Therapy
$714,123Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
High Energy and Spatial Resolution Multi-Isotope SPECT Imaging of Targeted Alpha-Emitters and their Daughters
$714,122George Sgouros · Johns Hopkins University · U01 · FY2023 · EB
Tumor gene expression in vitro and in vivo
$714,031Douglas R. Lowy · Basic Sciences · Z01 · FY2007 · CA
Chemoprevention of Prostate Cancer, HDAC Inhibition, and DNA Methylation
$713,980Emily Ho · Oregon State University · P01 · FY2013 · CA
Improvement and validation of the Spring System for Permanent Relief of Urinary Obstruction related to Benign Prostatic Hyperplasia (BPH)
$713,814Nicholas Damiano · Zenflow, Inc. · R44 · FY2019 · DK
Elucidation of the genetic mechanisms driving prostate tumorigenesis through integrative computational and functional approaches
$713,783Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2021 · CA